
Weight-loss experts predict 5 major treatment changes likely to emerge in 2026
Fox News
Weight-loss experts predict major shifts in 2026 as GLP-1 drugs, like Ozempic and Wegovy, evolve to multi-system metabolic modulators treating heart, liver and kidney health.
Angelica Stabile is a lifestyle reporter for Fox News Digital.
Dr. Peter Balazs, a hormone and weight loss specialist in New York and New Jersey, shared that the most important shift is likely to label GLP-1 drugs as "multi-system metabolic modulators" rather than "simple weight loss drugs."
More Related News













